Designer drug, designed therapy.
D000906:Antibodies / Q000494:pharmacology / Q000627:therapeutic use; D002265:Carboxylic Ester Hydrolases / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D003042:Cocaine / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics; D019970:Cocaine-Related Disorders / Q000188:drug therapy*; D015195:Drug Design; D006801:Humans; D008658:Inactivation, Metabolic
D000906:Antibodies; D002265:Carboxylic Ester Hydrolases; C019921:cocaine esterase; D003042:Cocaine